Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Ron Harvey who wrote (2174)	5/15/1998 6:40:00 PM
From: Keliven Wong	Read Replies (3) \| Respond to of 5736

Actually I think that you have it all wrong. Medicine keeps trying to claim that it is based in science and has been narrowing the focus of its jargon to give some precision. If the company is able to define a class of disease states that can be reliably diagnosed by color measurement, then it seems appropriate to use the term. As it stands, my understanding is that they construe their product to be a useful adjunct to non-invasively follow the serum bilirubin level. They have implied that they can follow the course of anemia. Are there other conditions? To group diseases by color harkens back to the days of animal magnetism. It reminds one of shamanism. At best it is a nineteenth centuryism - a pre-Flexnerian descriptive term designed to confuse as much as to enlighten. It falls into the time when doctors diagnosed diabetes by tasting urine, and talked learnedly about characteristic odors. Frankly in 1998 the term "chromogenic disease" sounds like the medical slang that residents would use in a satire like "The House of God". JMHO KW BTW there is a whole series of little-accepted diagnostic modalities such as diaphenography and thermography. Is that the niche this company is aiming toward?